B.R. Pharmaceuticals Limited - Accounts

B.R. PHARMACEUTICALS LIMITED - Company Information

2022-01-01 2022-12-31 false Capium Accounts Production 1.1 03164815 bus:FullAccounts 2022-01-01 2022-12-31 03164815 bus:FRS102 2022-01-01 2022-12-31 03164815 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 03164815 bus:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 03164815 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 03164815 2022-01-01 2022-12-31 03164815 2022-12-31 03164815 bus:RegisteredOffice 2022-01-01 2022-12-31 03164815 core:WithinOneYear 2022-12-31 03164815 core:AfterOneYear 2022-12-31 03164815 bus:Director1 2022-01-01 2022-12-31 03164815 bus:Director1 2022-12-31 03164815 bus:Director1 2021-01-01 2021-12-31 03164815 bus:Director2 2022-01-01 2022-12-31 03164815 bus:Director2 2022-12-31 03164815 bus:Director2 2021-01-01 2021-12-31 03164815 bus:Director3 2022-01-01 2022-12-31 03164815 bus:Director3 2022-12-31 03164815 bus:Director3 2021-01-01 2021-12-31 03164815 2021-01-01 03164815 bus:CompanySecretary1 2022-01-01 2022-12-31 03164815 bus:LeadAgentIfApplicable 2022-01-01 2022-12-31 03164815 2021-01-01 2021-12-31 03164815 2021-12-31 03164815 core:WithinOneYear 2021-12-31 03164815 core:AfterOneYear 2021-12-31 03164815 bus:EntityAccountantsOrAuditors 2021-01-01 2021-12-31 03164815 core:LandBuildings 2022-01-01 2022-12-31 03164815 core:LandBuildings 2022-12-31 03164815 core:LandBuildings 2021-12-31 03164815 core:PlantMachinery 2022-01-01 2022-12-31 03164815 core:PlantMachinery 2022-12-31 03164815 core:PlantMachinery 2021-12-31 03164815 core:MotorCars 2022-01-01 2022-12-31 03164815 core:MotorCars 2022-12-31 03164815 core:MotorCars 2021-12-31 03164815 core:FurnitureFittings 2022-01-01 2022-12-31 03164815 core:FurnitureFittings 2022-12-31 03164815 core:FurnitureFittings 2021-12-31 03164815 core:ComputerEquipment 2022-01-01 2022-12-31 03164815 core:ComputerEquipment 2022-12-31 03164815 core:ComputerEquipment 2021-12-31 03164815 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-12-31 03164815 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2021-12-31 03164815 core:CostValuation core:Non-currentFinancialInstruments 2022-12-31 03164815 core:CostValuation core:Non-currentFinancialInstruments 2021-12-31 03164815 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2022-12-31 03164815 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2022-12-31 03164815 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2022-12-31 03164815 core:Non-currentFinancialInstruments 2022-12-31 03164815 core:Non-currentFinancialInstruments 2021-12-31 03164815 core:ShareCapital 2022-12-31 03164815 core:ShareCapital 2021-12-31 03164815 core:SharePremium 2022-12-31 03164815 core:SharePremium 2021-12-31 03164815 core:RevaluationReserve 2022-12-31 03164815 core:RevaluationReserve 2021-12-31 03164815 core:RetainedEarningsAccumulatedLosses 2022-12-31 03164815 core:RetainedEarningsAccumulatedLosses 2021-12-31 03164815 dpl:Item1 2022-01-01 03164815 dpl:Item1 2022-12-31 03164815 dpl:Item1 2021-01-01 03164815 dpl:Item1 2021-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 03164815

England and Wales

B.R. PHARMACEUTICALS LIMITED

Unaudited Financial Statements

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

B.R. Pharmaceuticals Limited
Contents Page
For the year ended 31 December 2022

Company information	1
Statement of financial position	2
Notes to the financial statements	3

B.R. Pharmaceuticals Limited
Company Information
For the year ended 31 December 2022

Directors	Mr Z M M Abu Sheikha Mt T M M Abu Sheikha Mr O M M Abu Sheikha
Registered Number	03164815
Registered Office	Clayton Wood Close Leeds West Yorkshire LS16 6QE
Accountants	Ashfords Accountants Ltd 2 Manor Court Manor Mill Lane Leeds LS11 8LQ

B.R. Pharmaceuticals Limited
Statement of Financial Position
As at 31 December 2022

	Notes	2022 £	2021 £
Fixed assets
Intangible fixed assets	3	12,411	13,498
Tangible fixed assets	4	896,843	903,389
		909,254	916,887
Current assets
Stocks	5	502,651	504,925
Debtors	6	1,579,972	923,245
Cash at bank and in hand		1,327,955	1,378,728
		3,410,578	2,806,898
Creditors: amount falling due within one year	7	(574,490)	(567,880)
Net current assets		2,836,088	2,239,018

Total assets less current liabilities		3,745,342	3,155,905
Creditors: amount falling due after more than one year	8	(200,000)	(200,000)
Provisions for liabilities	9	(62,725)	(63,483)
Net assets		3,482,617	2,892,422

Capital and reserves
Called up share capital		70,000	70,000
Share premium account	10	20,000	20,000
Reserves	11	360,016	360,016
Profit and loss account		3,032,601	2,442,406
Shareholder's funds		3,482,617	2,892,422

For the year ended 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of Part 15 of the Companies Act 2006. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the board of directors on 29 September 2023 and were signed on its behalf by:

-------------------------------
Mr Z M M Abu Sheikha
Director

B.R. Pharmaceuticals Limited
Notes to the Financial Statements
For the year ended 31 December 2022

General Information

B.R. Pharmaceuticals Limited is a private company, limited by shares, registered in England and Wales, registration number 03164815, registration address Clayton Wood Close, Leeds, West Yorkshire, LS16 6QE.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)

Going concern basis

The directors believe that the company is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Operating lease rentals

Rentals payable under operating leases are charged against income on a straight line basis over the lease term.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Deferred taxation

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.

Intangible assets

Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.

Trade Mark
Trade Mark is stated at cost less amortization. Amortization is calculated on a straight line basis over the estimated expected useful economic life of the Trade Mark of 10 years.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Plant and Machinery	10% Straight Line
Motor Vehicles	25% Reducing Balance
Fixtures and Fittings	10% Straight Line
Computer Equipment	25% Straight Line

Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

Provisions

Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.

2.	Average number of employees Average number of employees during the year was 15 (2021 : 15).

Intangible fixed assets

Cost	Patents	Total
	£	£
At 01 January 2022	34,258	34,258
Additions	2,029	2,029
Disposals	-	-
At 31 December 2022	36,287	36,287
Amortisation
At 01 January 2022	20,760	20,760
Charge for year	3,116	3,116
On disposals	-	-
At 31 December 2022	23,876	23,876
Net book values
At 31 December 2022	12,411	12,411
At 31 December 2021	13,498	13,498

Tangible fixed assets

Cost or valuation	Land and Buildings	Plant and Machinery	Motor Vehicles	Fixtures and Fittings	Computer Equipment	Total
	£	£	£	£	£	£
At 01 January 2022	573,580	524,531	-	37,542	51,985	1,187,638
Additions	-	31,767	8,500	3,890	10,547	54,704
Disposals	-	-	-	-	-	-
At 31 December 2022	573,580	556,298	8,500	41,432	62,532	1,242,342
Depreciation
At 01 January 2022	-	215,745	-	20,287	48,217	284,249
Charge for year	-	53,942	1,948	2,395	2,965	61,250
On disposals	-	-	-	-	-	-
At 31 December 2022	-	269,687	1,948	22,682	51,182	345,499
Net book values
Closing balance as at 31 December 2022	573,580	286,611	6,552	18,750	11,350	896,843
Opening balance as at 01 January 2022	573,580	308,786	-	17,255	3,768	903,389

Stocks

	2022 £		2021 £
Stocks	502,651		504,925
	502,651		504,925

Debtors: amounts falling due within one year

	2022 £	2021 £
Trade Debtors	614,537	747,351
Other Debtors	965,435	175,894
	1,579,972	923,245

Creditors: amount falling due within one year

	2022 £	2021 £
Trade Creditors	284,257	334,136
Taxation and Social Security	174,045	208,235
Other Creditors	116,188	25,509
	574,490	567,880

Creditors: amount falling due after more than one year

	2022 £		2021 £
Other Creditors	200,000		200,000
	200,000		200,000

Provisions for liabilities

	2022 £	2021 £
Deferred Tax	61,420	63,483
Pension Provisions	1,305	0
	62,725	63,483

10.

Share premium account

	2022 £		2021 £
Equity Share Premium	20,000		20,000
	20,000		20,000

11.

Reserves

	2022 £		2021 £
Revaluation Reserve	360,016		360,016
	360,016		360,016

12.	Controlling Party The company is under the control of its directors.